Drug firm Elder Pharmaceuticals is eyeing 20% growth in revenues to around Rs 1,200 crore in the current fiscal on the back of new product launches.

"With maximum traction in women's healthcare, wound care and the nutraceutical segments last year, it had a turnover of almost Rs 1,000 crore on a consolidated basis and it is estimated at current growth of 20%, we will be on our expected target of Rs 1,200 crore during the current fiscal 2011-12," an official quoted.

The company is looking to achieve the growth in the domestic market by its existing strong range of branded products including Shelcal, Eldervit and Chymoral as well as further brand building of its new product range.

The Mumbai-based firm, which derives 95% of its revenues from the domestic market, is also expecting a better performance from its in-licensed brands and overseas subsidiaries.

The company currently has 24 in-licence agreements with various firms for the domestic market.

A senior official said that they are enhancing their presence in the field of pain management, where we have identified chronic diseases like arthritis and cartilage disease and have specific arrangement with two foreign companies to market the products. Similarly nutraceuticals and active pharma ingredients (API) are other areas where the company is expanding its operations.

The company has recently received accreditation from Ministry of Health, Japan, is looking to launch three products in the lucrative market.

Ten companies will start their units in four SEZs of the state following a nod by the zonal director of SEZs. Together, these companies will invest Rs 140 crore in the first phase in technology, textile and pharma sectors.

The SEZs that will receive the new clients are Aqualine SEZ (Gandhinagar), GIDC Electronics Park (Gandhinagar), GIDC Apparel Park (Ahmedabad) and JB Pharma SEZ in Bharuch.

The Aqualine SEZ for Information Technology (IT) and IT enabled Services (ITeS), had received applications from Ahmedabad-based Third Eye Enterprise, Gandhingar-based Roving Radiology, Mumbai-based Annet Technologies, Ahmedabad-based Infosense Services, Ahmedabad-based Raegan International and Ahmedabad-based Plenar solutions.

Third Eye will set up an online and offline Software Development Services centre, while Annet and Plenear Soutions will set up an IT-ITeS centre. Similarly, Infosense will start a Web Services and Project Management Centre; Raegan International will set up a BPO-KPO centre, while Roving Technologies will set up a Knowledge Process Outsourcing centre for Tele-Radiology. Togather, these companies will invest Rs 8 crore initially and employ around 400 persons.

Ghaziabad-based Compark E-Services Private Limited will invest close to Rs 60 lakh and employ around 150 people at Gandhinagar-based GIDC Electronics Park, a SEZ for IT-ITeS sector.

Ahmedabad-based GIDC Apparel Park will see investments from Ahmedabad-based Mahavir Tex Fab, who will manufacture shirts, trousers and other textile products. Ahmedabad-based Utkarsh Exim Private Limited will manufacture aprons and gloves for medical use in the SEZ. Together, the companies will invest Rs 1 crore initially and employ close to 300 people.

Pune-based Biodeal Laboratories Private Limited has received a nod to set up facilty for making nasal spray, drops, inhalers, dry powders and tablets at J B Pharma SEZ in Bharuch district. The company will pump in over Rs 130 crore and is expected to employ close to 700 persons at the SEZ.